Pediatric Rheumatology Research Annual Scientific Meeting

描述（由申请人提供）：儿科风湿病研究年度科学会议将是儿科风湿病学界分享最先进的科学方法，科学机会和新技术的论坛。这项建议是我们先前为2006年和2007年会议提供支持的会议拨款的延续。本次会议由儿童关节炎和风湿病研究联盟（CARRA）共同主办，该联盟是一个由美国和加拿大大多数儿科风湿病学家组成的研究网络。本次会议预计为期2天半，所有CARRA成员、儿科风湿病学界、对儿科风湿病研究感兴趣的个人以及相关领域（内科风湿病学、免疫学、流行病学和其他儿科研究网络）的特邀演讲者和专家都将参加。会议的形式将是对每一种儿科风湿病的当前科学进展、知识差距、科学机会和技术进步进行说教性介绍。将提供关于临床研究和临床试验的实验设计，临床和转化研究的新方法，拨款写作和其他感兴趣领域的具体讲习班。便利的互动式会议将确定每个主要疾病领域的关键研究需要和机会，并将未来发展的科学优先事项纳入具体的研究项目。将确定和培养合作机会和指导关系，并确定与临床研究问题协调的转化研究机会。本次会议的目的是：1)更新对儿童风湿病发病机制（免疫、遗传和炎症）、流行病学以及当前和创新治疗方法的理解进展；2)为儿科风湿病研究界提供发展合作和指导的论坛；3)提供与儿科风湿病研究相关的主要领域的培训和教育。这次会议将成为CARRA实现其主要使命的主要途径之一，即促进高质量研究的发展，并最终创建一个包括每种儿科风湿病相关研究项目的研究组合。

DESCRIPTION (provided by applicant): The Pediatric Rheumatology Research Annual Scientific Meeting will be the forum for the pediatric rheumatology community for sharing the scientific state-of-the-art methodologies, scientific opportunities and new technologies. This proposal is a renewal of our previous conference grant which provided support for the 2006 and 2007 meetings. The meeting is co-sponsored by the Childhood Arthritis and Rheumatology Research Alliance (CARRA), a research network comprising the majority of pediatric rheumatologists in the US and Canada. This meeting is conceived to be 2 1/2 days and all members of CARRA, the pediatric rheumatology community, individuals interested in pediatric rheumatic disease research and invited speakers and experts in related fields (internal medicine rheumatology, immunology, epidemiology, and other pediatric research networks). The format will be didactic presentations on the current scientific advances in each of the pediatric rheumatic disease, gaps in knowledge, scientific opportunities and technologic advances. Specific workshops on experimental design in clinical research and clinical trials, new methodologies for clinical and translational research, grant writing, and other areas of interest will be offered. Facilitated interactive sessions will identify the key research needs and opportunities in each of the major disease areas, and develop scientific priorities for future development into specific research projects. Collaborative opportunities and mentoring relationships will be identified and fostered, and translational research opportunities will be identified in coordination with clinical research questions. The objectives of this meeting are to: 1) Update the progress in understanding the pathogenesis (immune, genetic, and inflammatory), epidemiology, and current and innovative therapeutic approaches in pediatric rheumatic diseases; 2) Provide a forum for development of collaborations and mentoring for the pediatric rheumatology research community; and 3) Provide training and education in major areas relevant to pediatric rheumatology research. This meeting will be one of the major avenues whereby CARRA will achieve its primary mission of facilitating the development of high-quality research studies and ultimately creating a research portfolio that includes relevant research projects in every type of pediatric rheumatic disease.